Whisper it, but we may finally be seeing the IPO window reopening in 2026. | Whisper it, but we may finally be seeing the IPO window reopening in 2026.
As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18th year SAN FRANCISCO, CA, UNITED STATES, February 10, ...
2026 could be a big year for this company.
Vinay Prasad is tightening the screws at the FDA, overruling staff and signaling a tougher stance on vaccines and gene ...
Four drug companies — Agomab Therapeutics, Eikon Therapeutics, Spyglass Pharma, and Veradermics — went public this week, ...
The latest firm to top up its venture capital coffers is Austin, Texas-based Santé Ventures, which on Monday announced its ...
AI-assisted drug discovery isn’t just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI ...
SHANDONG, SHANDONG, CHINA, January 28, 2026 /EINPresswire.com/ -- In the rapidly evolving world of pet care, where "pet ...
The companies Aktis Oncology, Alumis, and Parabilis Medicines bagged the biggest biotech funding rounds overall in January ...
This closing forms a natural continuum following the €7.6 million France 2030 i-Démo grant announced last year, and the very ...
Two biotechs take full floors at Waltham’s GENESIS 21 Hickory — about 48K sq ft added to the Route 128 lab campus.
Orna Therapeutics, which engineers immune cells inside the body, will fold into one of the world’s largest drugmakers. The post Eli Lilly snaps up Watertown biotech in $2.4 billion deal appeared first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results